Skip to main content
Published locations for ER+ BC: Reduced recurrence with aromatase inhibitors vs. tamoxifen in premenopausal women
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
ER+ BC: Reduced recurrence with aromatase inhibitors vs. tamoxifen in premenopausal women
User login
Username
Password
Reset your password
/content/er-bc-reduced-recurrence-aromatase-inhibitors-vs-tamoxifen-premenopausal-women
/hematology-oncology/article/252016/breast-cancer/er-bc-reduced-recurrence-aromatase-inhibitors-vs
/breast-cancer-icymi/article/252016/breast-cancer/er-bc-reduced-recurrence-aromatase-inhibitors-vs